Skip to main content
. 2020 Oct 25;15(4):459–469. doi: 10.18502/jovr.v15i4.7786

Table 3.

Immunomulatory therapy before starting the infliximab therapy in patients with HLA-B27 ocular inflammation


Immunomodulatory therapy Number (%)
Methotrexate 10 (41.6%)
Mycophenolate Mofetil 5 (20.8%)
Humira 5 (20.8%)
Cyclosporine 2 (8.33%)
Chlorambucil 1 (4.16%)
Daclizumab 1 (4.16%)
Etanercept 1 (4.16%)
Azathioprine 1 (4.16%)
Celecoxib 1 (4.16%)
None 4 (16.6%)